Impact of anti-rheumatic treatment on immunogenicity of pandemic H1N1 influenza vaccine in patients with arthritis

Persistence of antibody response 1.5 years after vaccination using 7-valent pneumococcal conjugate vaccine in patients with arthritis treated with different antirheumatic drugs

(2013) Meliha Crnkic Kapetanovic et al.   ARTHRITIS RESEARCH & THERAPY

Long-term immunogenicity of two doses of 2009 A/H1N1v vaccine with and without AS03A adjuvant in HIV-1-infected adults

(2012) Christine Durier et al.   AIDS

Impact of tocilizumab therapy on antibody response to influenza vaccine in patients with rheumatoid arthritis

(2012) Shunsuke Mori et al.   ANNALS OF THE RHEUMATIC DISEASES

Rituximab-Treated Patients Have a Poor Response to Influenza Vaccination

(2012) Robert A. Eisenberg et al.   JOURNAL OF CLINICAL IMMUNOLOGY

Immunogenicity and Safety of Varying Dosages of a Monovalent 2009 H1N1 Influenza Vaccine Given With and Without AS03 Adjuvant System in Healthy Adults and Older Persons

(2012) L. A. Jackson et al.   JOURNAL OF INFECTIOUS DISEASES

Safety and Long-term Humoral Immune Response in Adults After Vaccination With an H1N1 2009 Pandemic Influenza Vaccine With or Without AS03 Adjuvant

(2012) Murdo Ferguson et al.   JOURNAL OF INFECTIOUS DISEASES

TNF blockers show distinct patterns of immune response to the pandemic influenza A H1N1 vaccine in inflammatory arthritis patients

(2012) I. L. A. Franca et al.   RHEUMATOLOGY

Effective seroconversion and safety following the pandemic influenza vaccination (anti-H1N1) in patients with juvenile idiopathic arthritis

(2012) NE Aikawa et al.   SCANDINAVIAN JOURNAL OF RHEUMATOLOGY

Abatacept and reduced immune response to pandemic 2009 influenza A/H1N1 vaccination in patients with rheumatoid arthritis

(2012) Ana C. Ribeiro et al.   ARTHRITIS CARE & RESEARCH

The effect of smoking and alcohol consumption on markers of systemic inflammation, immunoglobulin levels and immune response following pneumococcal vaccination in patients with arthritis

(2012) Carmen Roseman et al.   ARTHRITIS RESEARCH & THERAPY

Evaluation of immune response following one dose of an AS03A-adjuvanted H1N1 2009 pandemic influenza vaccine in Japanese adults 65 years of age or older

(2012) Hideyuki Ikematsu et al.   Human Vaccines & Immunotherapeutics

Characterization and long-term persistence of immune response following two doses of an AS03A-adjuvanted H1N1 influenza vaccine in healthy Japanese adults

(2012) Hideyuki Ikematsu et al.   Human Vaccines & Immunotherapeutics

Antibody response is reduced following vaccination with 7-valent conjugate pneumococcal vaccine in adult methotrexate-treated patients with established arthritis, but not those treated with tumor necrosis factor inhibitors

(2011) Meliha Crnkic Kapetanovic et al.   ARTHRITIS AND RHEUMATISM

Impact of synthetic and biologic disease-modifying antirheumatic drugs on antibody responses to the AS03-adjuvanted pandemic influenza vaccine: A prospective, open-label, parallel-cohort, single-center study

(2011) Cem Gabay et al.   ARTHRITIS AND RHEUMATISM

Glucocorticoid: Major Factor for Reduced Immunogenicity of 2009 Influenza A (H1N1) Vaccine in Patients with Juvenile Autoimmune Rheumatic Disease

(2011) N. E. AIKAWA et al.   JOURNAL OF RHEUMATOLOGY

Protective effect of A/H1N1 vaccination in immune-mediated disease--a prospectively controlled vaccination study

(2011) S. Adler et al.   RHEUMATOLOGY

Low level of seroconversion after a novel influenza A/H1N1/2009 vaccination in Japanese patients with rheumatoid arthritis in the 2009 season

(2011) Masahiro Iwamoto et al.   RHEUMATOLOGY INTERNATIONAL

Efficacy and safety of vaccination against pandemic 2009 influenza A (H1N1) virus among patients with rheumatic diseases

(2011) Ori Elkayam et al.   ARTHRITIS CARE & RESEARCH

Influenza virus vaccines: lessons from the 2009 H1N1 pandemic

(2011) Andrew J Broadbent et al.   Current Opinion in Virology

AS03A‐Adjuvanted Influenza A (H1N1) 2009 Vaccine for Adults up to 85 Years of Age

(2010) François Roman et al.   CLINICAL INFECTIOUS DISEASES

Immunogenicity and safety of a two-dose schedule of whole-virion and AS03A-adjuvanted 2009 influenza A (H1N1) vaccines: a randomised, multicentre, age-stratified, head-to-head trial

(2010) Karl G Nicholson et al.   LANCET INFECTIOUS DISEASES

Humoral responses after influenza vaccination are severely reduced in patients with rheumatoid arthritis treated with rituximab

(2009) Sander van Assen et al.   ARTHRITIS AND RHEUMATISM

The aging of the immune system

(2009) Daniela Weiskopf et al.   TRANSPLANT INTERNATIONAL

Rapid Decline of Influenza Vaccine–Induced Antibody in the Elderly: Is It Real, or Is It Relevant?

(2008) Danuta M. Skowronski et al.   JOURNAL OF INFECTIOUS DISEASES